Temozolomide sensitivity of malignant glioma cell lines – a systematic review assessing consistencies between in vitro studies

Abstract Background Malignant glioma cell line models are integral to pre-clinical testing of novel potential therapies. Accurate prediction of likely efficacy in the clinic requires that these models are reliable and consistent. We assessed this by examining the reporting of experimental conditions...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Michael T. C. Poon, Morgan Bruce, Joanne E. Simpson, Cathal J. Hannan, Paul M. Brennan
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
GBM
Accès en ligne:https://doaj.org/article/da02e9ee3efb494ea3436c9175d4c261
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!